nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non–Small-Cell Lung Cancer
|
Woodard, Gavitt A. |
|
2018 |
19 |
1 |
p. 58-64 |
artikel |
2 |
An Evolving Algorithm to Select and Sequence Therapies in EGFR Mutation-positive NSCLC: A Strategic Approach
|
Melosky, Barbara |
|
2018 |
19 |
1 |
p. 42-50 |
artikel |
3 |
A Review of Regimens Combining Pemetrexed With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the Treatment of Advanced Nonsquamous Non–Small-Cell Lung Cancer
|
Yang, James Chih-Hsin |
|
2018 |
19 |
1 |
p. 27-34 |
artikel |
4 |
Clinical Implications of the T790M Mutation in Disease Characteristics and Treatment Response in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Non–Small-Cell Lung Cancer (NSCLC)
|
Gaut, Daria |
|
2018 |
19 |
1 |
p. e19-e28 |
artikel |
5 |
Combination Strategies on the Basis of Immune Checkpoint Inhibitors in Non–Small-Cell Lung Cancer: Where Do We Stand?
|
Qiao, Meng |
|
2018 |
19 |
1 |
p. 1-11 |
artikel |
6 |
Combination Therapy of Radiotherapy and Anti-PD-1/PD-L1 Treatment in Non–Small-cell Lung Cancer: A Mini-review
|
Takamori, Shinkichi |
|
2018 |
19 |
1 |
p. 12-16 |
artikel |
7 |
Comparative Effectiveness and Resource Usage in Patients Receiving First-line Taxol-based Chemotherapy for Stage IV NSCLC
|
Tamura, Tomohiro |
|
2018 |
19 |
1 |
p. e67 |
artikel |
8 |
Double Trouble: A Case Series on Concomitant Genetic Aberrations in NSCLC
|
Van Der Steen, Nele |
|
2018 |
19 |
1 |
p. 35-41 |
artikel |
9 |
Editorial Board
|
|
|
2018 |
19 |
1 |
p. A7 |
artikel |
10 |
FDG PET/CT Overcomes Discordance Between Clinical and Pathologic TNM Classification of Small-size Primary Lung Cancer: Influence on Postoperative Prognosis
|
Umakoshi, Hiroyasu |
|
2018 |
19 |
1 |
p. e37-e45 |
artikel |
11 |
High-resolution Computed Tomography Features Distinguishing Benign and Malignant Lesions Manifesting as Persistent Solitary Subsolid Nodules
|
Yang, Wenjia |
|
2018 |
19 |
1 |
p. e75-e83 |
artikel |
12 |
Identifying the Optimal Radiation Dose in Locally Advanced Non–Small-cell Lung Cancer Treated With Definitive Radiotherapy Without Concurrent Chemotherapy
|
Sonnick, Mark A. |
|
2018 |
19 |
1 |
p. e131-e140 |
artikel |
13 |
Isolated Brain Metastases as the First Relapse After the Curative Surgical Resection in Non–Small-Cell Lung Cancer Patients With an EGFR Mutation
|
Sadoyama, Shinko |
|
2018 |
19 |
1 |
p. e29-e36 |
artikel |
14 |
Lazarus Syndrome With Crizotinib in a Non–Small Cell Lung Cancer Patient With ROS1 Rearrangement and Disseminated Intravascular Coagulation
|
Brosseau, Solenn |
|
2018 |
19 |
1 |
p. e57-e61 |
artikel |
15 |
Letter to the Editor
|
Vigliar, Elena |
|
2018 |
19 |
1 |
p. e149 |
artikel |
16 |
Local Radiotherapy Intensification for Locally Advanced Non–small-cell Lung Cancer – A Call to Arms
|
Kalman, Noah S. |
|
2018 |
19 |
1 |
p. 17-26 |
artikel |
17 |
Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study
|
Pilotto, Sara |
|
2018 |
19 |
1 |
p. 93-104 |
artikel |
18 |
Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non–Small-cell Lung Cancer: SWOG S0635 and S0636 Trials
|
West, Howard L. |
|
2018 |
19 |
1 |
p. 84-92 |
artikel |
19 |
Presence of Even a Small Ground-Glass Component in Lung Adenocarcinoma Predicts Better Survival
|
Berry, Mark F. |
|
2018 |
19 |
1 |
p. e47-e51 |
artikel |
20 |
Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non–Small-cell Lung Cancer
|
Noma, Daisuke |
|
2018 |
19 |
1 |
p. e109-e122 |
artikel |
21 |
Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on 18F-FDG PET/CT in Patients With Limited-stage Small-cell Lung Cancer With Lymph Node Involvement
|
Jin, Feng |
|
2018 |
19 |
1 |
p. e101-e108 |
artikel |
22 |
Prognostic Value of Radiation Pneumonitis After Stereotactic Body Radiotherapy: Effect of Pulmonary Emphysema Quantitated Using CT Images
|
Yamamoto, Takaya |
|
2018 |
19 |
1 |
p. e85-e90 |
artikel |
23 |
Prospective Clinical Integration of an Amplicon-Based Next-Generation Sequencing Method to Select Advanced Non–Small-Cell Lung Cancer Patients for Genotype-Tailored Treatments
|
Zugazagoitia, Jon |
|
2018 |
19 |
1 |
p. 65-73.e7 |
artikel |
24 |
Quantitatively Excessive Normal Tissue Toxicity and Poor Target Coverage in Postoperative Lung Cancer Radiotherapy Meta-analysis
|
Abuodeh, Yazan |
|
2018 |
19 |
1 |
p. e123-e130 |
artikel |
25 |
Radical Treatment of Stage II Non–small-cell Lung Cancer With Nonsurgical Approaches: A Multi-institution Report of Outcomes
|
Dudani, Shaan |
|
2018 |
19 |
1 |
p. e11-e18 |
artikel |
26 |
Randomized Phase III Study of Cisplatin With Pemetrexed and Cisplatin With Vinorelbine for Completely Resected Nonsquamous Non–Small-Cell Lung Cancer: The JIPANG Study Protocol
|
Yamamoto, Nobuyuki |
|
2018 |
19 |
1 |
p. e1-e3 |
artikel |
27 |
Retreatment With Osimertinib Following Pneumonitis
|
Nagasaka, Misako |
|
2018 |
19 |
1 |
p. e53-e55 |
artikel |
28 |
ROS1-rearranged Non–Small Cell Lung Cancers With Concomitant Oncogenic Driver Alterations: About Some Rare Therapeutic Dilemmas
|
Lambros, Laetitia |
|
2018 |
19 |
1 |
p. e73-e74 |
artikel |
29 |
Squamous Cell Carcinoma Transformation from EGFR-mutated Lung Adenocarcinoma: A Case Report and Literature Review
|
Izumi, Hiroki |
|
2018 |
19 |
1 |
p. e63-e66 |
artikel |
30 |
Surgery Versus Conventional Radiation Therapy for T1-2 N0 M0 Small-cell Lung Cancer: A Fair Comparison?
|
Verma, Vivek |
|
2018 |
19 |
1 |
p. e69-e70 |
artikel |
31 |
Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy
|
Felip, Enriqueta |
|
2018 |
19 |
1 |
p. 74-83.e11 |
artikel |
32 |
Table of Contents
|
|
|
2018 |
19 |
1 |
p. A9-A10, A12-A15 |
artikel |
33 |
The Effect of Primary Care Physician Knowledge of Lung Cancer Screening Guidelines on Perceptions and Utilization of Low-Dose Computed Tomography
|
Raz, Dan J. |
|
2018 |
19 |
1 |
p. 51-57 |
artikel |
34 |
The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non–small-cell Lung Cancer
|
McGee, Sharon F. |
|
2018 |
19 |
1 |
p. e91-e99 |
artikel |
35 |
Thromboembolism in Anaplastic Lymphoma Kinase–Rearranged Non–Small Cell Lung Cancer
|
Alexander, Marliese |
|
2018 |
19 |
1 |
p. e71-e72 |
artikel |
36 |
Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non–Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis
|
Otsubo, Kohei |
|
2018 |
19 |
1 |
p. e5-e9 |
artikel |
37 |
Validation of the Disease-Specific GPA for Patients With 1 to 3 Synchronous Brain Metastases in Newly Diagnosed NSCLC
|
Woody, Neil M. |
|
2018 |
19 |
1 |
p. e141-e147 |
artikel |